Mirion Technologies, Inc. (NYSE:MIR) CEO Thomas D. Logan has recently sold a total of $78,549 worth of company stock, according to the latest SEC filings. The transactions took place on September 24, 2024, and involved the sale of Class A common stock at prices ranging from $10.32 to $10.75.
The sale was executed under a pre-arranged 10b5-1 trading plan, which allows company insiders to set up a predetermined schedule for buying and selling stock at a future date. This plan was adopted by Aere Perennius, LLC, a limited liability company holding interests in trusts for the benefit of Logan's adult children, with Mary Logan Martineau, formerly known as Mary Hancock Logan, serving as Investment Trustee with sole voting and dispositive power.
The SEC filing also detailed a redemption and conversion of Class B common stock into Class A common stock held by Aere Perennius, LLC, which was carried out on a one-for-one basis. The transaction resulted in the cancellation of 7,500 shares of Class B common stock and the issuance of an equal number of Class A shares. This conversion did not involve any monetary transaction and was part of the same 10b5-1 plan.
Following the sale, the direct holdings of Class A common stock by Aere Perennius, LLC were reduced to zero, while the indirect holdings of Class B common stock stood at 2,558,871 shares. The direct holdings of Class A and Class B common stock by Thomas D. Logan are 755,790 and 1,544,017 shares, respectively.
Investors tracking insider transactions at Mirion Technologies will note that these sales and conversions reflect changes in the ownership structure of the company's stock, providing insights into executive moves within the organization.
In other recent news, Mirion Technologies reported robust Q2 2024 earnings, revealing a significant strategic partnership agreement with EDF (EPA:EDF) and a revised financial outlook for the year. The company saw steady organic revenue growth in its Technologies and Medical segments, despite flat order growth compared to the previous year. Adjusted EBITDA targets for 2024 were raised to between $195 million and $205 million. Additionally, Mirion Technologies announced key organizational changes, including the appointment of Luis Rivera as EVP of the Medical Group and Mark Siviter as Chief Revenue Officer.
Mirion Technologies also signed an exclusive content supply agreement with EDF for nuclear new build projects. Despite market disruptions in China due to anti-corruption measures, the company maintains a strong competitive position, particularly in the Nuclear segment, through the EDF partnership. The Nuclear Medicine business, the fastest-growing segment in the Medical division, shows promising potential.
Analysts from B.Riley initiated coverage of Mirion Technologies with a Buy rating and a price target of $14.00, highlighting the company's strong market presence and operational efficiency. These are among the recent developments for the company.
InvestingPro Insights
In light of the recent insider transactions at Mirion Technologies, Inc. (NYSE:MIR), investors may find it beneficial to consider some key financial metrics and expert analysis from InvestingPro. As of the latest data, Mirion Technologies has a market capitalization of approximately $2.29 billion, reflecting the company's valuation in the eyes of the market. Despite a challenging period, the company has shown resilience with a revenue growth of 8.34% over the last twelve months as of Q2 2024, indicating a potential turnaround in its financial performance.
One of the notable InvestingPro Tips for Mirion Technologies is the expectation of net income growth this year. This is a positive signal for investors, as it suggests a potential improvement in the company's profitability. Additionally, the company's liquid assets exceed its short-term obligations, which implies a strong liquidity position and the ability to cover immediate financial needs.
However, it is important to note that Mirion Technologies is trading at a high EBIT valuation multiple and has been flagged by analysts for not being profitable over the last twelve months. This could be a point of concern for investors seeking immediate profitability. Furthermore, the company's stock is trading near its 52-week high, with the price at the previous close standing at $10.67, which is 93.55% of the 52-week high. This could indicate that the stock is currently valued at a premium by the market.
For investors looking for more in-depth analysis, there are additional InvestingPro Tips available at https://www.investing.com/pro/MIR, which could provide further insights into Mirion Technologies’ financial health and future outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.